Main Menu
Menu

Blog

Publish Date
Blog
Why C4IP Supports the Patent Eligibility Restoration Act of 2025 (PERA)

This chaotic area of law harms American innovation and competitiveness Without Congressional consideration or endorsement, the Supreme Court has fundamentally altered the...

BlogFact Checks
Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry

Myths about how patent rights affect competition within the drug industry remain a pressing issue for innovators. Although strong patents play a...

Blog
This Month in IP: August 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From entertainment...

Blog
C4IP Coalition Updates: August 2025

August Highlights: Setting the Record Straight on the DOJ/FTC Listening Sessions The Department of Justice and Federal Trade Commission recently hosted listening...

BlogOp-Eds
To Defend Nations, NATO Must Defend Innovation

In a new piece for Newsweek, Mircea Geoană, former NATO deputy secretary general and president of the Aspen Institute Romania, and Andrei...

Newsweek
BlogFact Checks
Fact Check: IP Protections Power the U.S. Innovation Economy. MFN Would Undermine this System.

In recent months, federal policymakers have renewed calls for “Most-Favored-Nation” (MFN) drug pricing, which would tie the price of medicines in the...

Blog
Inventor Spotlight: Charles W. Hull

C4IP is honoring Charles W. Hull (born 1939), who has transformed manufacturing, medicine, and design through his invention of stereolithography — better...

Blog
C4IP Coalition Updates: July 2025

July Highlights: Congress Rejects Big Tech’s Push to Block AI Rules During last month’s deliberations on the One Big Beautiful Bill Act...

Blog
This Month in IP: July 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From car...

BlogFact Checks
Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation

Earlier this year, a coalition of technology industry lobbyists sent a letter to President Trump urging his administration to weaken protections for...

Blog
Why C4IP Opposes the Drug Competition Enhancement Act and the Affordable Prescriptions for Patients Act

Congress is currently considering several ill-conceived bills that purport to address abuses in the patent system, but would, in reality, weaken core...

Blog
What the Numbers Say: Patent Quality in the United States is Strong

A newly-released policy brief from the IP Policy Institute at the University of Akron School of Law reaffirms the finding from a...

Blog:

Blog:

Why C4IP Supports the Patent Eligibility Restoration Act of 2025 (PERA),

09/25/2025
Blog:

Blog, Fact Checks:

Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry,

09/19/2025
Blog:

Blog:

This Month in IP: August 2025,

09/09/2025
Blog:

Blog:

C4IP Coalition Updates: August 2025,

09/09/2025
Op-Eds:

Blog, Op-Eds:

To Defend Nations, NATO Must Defend Innovation,

09/08/2025
Blog:

Blog, Fact Checks:

Fact Check: IP Protections Power the U.S. Innovation Economy. MFN Would Undermine this System.,

08/14/2025
Blog:

Blog:

Inventor Spotlight: Charles W. Hull,

08/07/2025
Blog:

Blog:

C4IP Coalition Updates: July 2025,

08/01/2025
Blog:

Blog:

This Month in IP: July 2025,

08/01/2025
Blog:

Blog, Fact Checks:

Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation,

07/25/2025
Blog:

Blog:

Why C4IP Opposes the Drug Competition Enhancement Act and the Affordable Prescriptions for Patients Act,

07/18/2025
Blog:

Blog:

What the Numbers Say: Patent Quality in the United States is Strong,

07/14/2025
Scroll to Top